PURPOSE: To investigate possible alterations of erythrocyte aggregation and deformability, which are factors that can influence blood flow, in human immunodeficiency virus (HIV)-infected individuals and to determine whether these factors are related to the severity of immunodeficiency. METHODS: Laboratory evaluations were performed on 46 HIV-infected individuals and 44 HIV-negative control subjects. Current and nadir (lowest previous) CD4+ T-lymphocyte counts were identified for each subject. Erythrocyte aggregation was measured using a fully automatic erythrocyte aggregometer. Factors related to erythrocyte aggregation were also determined: erythrocyte sedimentation rate (ESR), zeta sedimentation ratio (ZSR), and plasma fibrinogen levels. Erythrocyte deformability was observed at various fluid shear stress levels, with a laser diffraction ektacytometer. Correlations were sought between each of these measures and current or nadir CD4+ T-lymphocyte counts, and each measure was compared between three subgroups based on current and nadir CD4+ T-lymphocyte counts (severely immunosuppressed, immune reconstituted, never severely immunosuppressed). RESULTS: The following parameters were significantly different between HIV-infected subjects and controls: increased erythrocyte aggregation, at stasis (P < 0.001) and low shear stress (P < 0.001), increased ESR (P < 0.001), increased ZSR (P < 0.028), increased serum fibrinogen (P = 0.015), and decreased erythrocyte deformability (P < 0.001). Only erythrocyte aggregation at stasis correlated significantly with current CD4+ T-lymphocyte count (r = - 0.344, P = 0.022). None of the parameters was significantly different between HIV-infected subgroups. CONCLUSIONS: Increased aggregation and decreased deformability of erythrocytes are associated with HIV-infection regardless of the severity of immunodeficiency. HIV-infected individuals may be at risk for progressive retinal microvascular damage from persistent hemorheologic abnormalities, despite immune reconstitution associated with potent antiretroviral drug therapies.
PURPOSE: To investigate possible alterations of erythrocyte aggregation and deformability, which are factors that can influence blood flow, in human immunodeficiency virus (HIV)-infected individuals and to determine whether these factors are related to the severity of immunodeficiency. METHODS: Laboratory evaluations were performed on 46 HIV-infected individuals and 44 HIV-negative control subjects. Current and nadir (lowest previous) CD4+ T-lymphocyte counts were identified for each subject. Erythrocyte aggregation was measured using a fully automatic erythrocyte aggregometer. Factors related to erythrocyte aggregation were also determined: erythrocyte sedimentation rate (ESR), zeta sedimentation ratio (ZSR), and plasma fibrinogen levels. Erythrocyte deformability was observed at various fluid shear stress levels, with a laser diffraction ektacytometer. Correlations were sought between each of these measures and current or nadir CD4+ T-lymphocyte counts, and each measure was compared between three subgroups based on current and nadir CD4+ T-lymphocyte counts (severely immunosuppressed, immune reconstituted, never severely immunosuppressed). RESULTS: The following parameters were significantly different between HIV-infected subjects and controls: increased erythrocyte aggregation, at stasis (P < 0.001) and low shear stress (P < 0.001), increased ESR (P < 0.001), increased ZSR (P < 0.028), increased serum fibrinogen (P = 0.015), and decreased erythrocyte deformability (P < 0.001). Only erythrocyte aggregation at stasis correlated significantly with current CD4+ T-lymphocyte count (r = - 0.344, P = 0.022). None of the parameters was significantly different between HIV-infected subgroups. CONCLUSIONS: Increased aggregation and decreased deformability of erythrocytes are associated with HIV-infection regardless of the severity of immunodeficiency. HIV-infected individuals may be at risk for progressive retinal microvascular damage from persistent hemorheologic abnormalities, despite immune reconstitution associated with potent antiretroviral drug therapies.
Authors: Sapna Gangaputra; Partho S Kalyani; Amani A Fawzi; Mark L Van Natta; Larry D Hubbard; Ronald P Danis; Jennifer E Thorne; Gary N Holland Journal: Am J Ophthalmol Date: 2011-10-22 Impact factor: 5.258
Authors: Richard Omoregie; Judith E Adeghe; Helen O Ogefere; Evelyn U Omokaro; Chinedu C Ekeh Journal: Afr Health Sci Date: 2008-12 Impact factor: 0.927
Authors: Jessica G Shantha; Sara C Auld; Casey Anthony; Laura Ward; Max W Adelman; Cheryl L Maier; Kenneth W Price; Jesse T Jacob; Tolulope Fashina; Casey Randleman; Lucy T Xu; Joshua Barnett; Ofer Sadan; Prem A Kandiah; Jay B Varkey; Colleen S Kraft; Nadine Rouphael; Susanne Linderman; Rafi Ahmed; Carolyn Drews-Botsch; Jesse J Waggoner; Max Weinmann; David J Murphy; Steven Yeh Journal: Ocul Immunol Inflamm Date: 2021-08-31 Impact factor: 3.728
Authors: Melody E Roelke; Meredith A Brown; Jennifer L Troyer; Hanlie Winterbach; Christiaan Winterbach; Graham Hemson; Dahlem Smith; Randall C Johnson; Jill Pecon-Slattery; Alfred L Roca; Kathleen A Alexander; Lin Klein; Paolo Martelli; Karthiyani Krishnasamy; Stephen J O'Brien Journal: Virology Date: 2009-05-22 Impact factor: 3.616